News

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...
Some of the potential iterations of delivery methods Eli Lilly considered for ... drugs move from manufacturers like Lilly, through large distributors and pharmacy benefit managers who ...
Eli Lilly is partnering ... “Now, [Lilly and others] are like, ‘That's a great idea. We can do that too.’” LillyDirect also operates a self-pay pharmacy arm through dispensing provider ...
Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...